Emerging Clinical Initiatives in Phamaceutical Development
Sponsor(s): Biostatistics and Bioinformatics
Cost: https://conf.events.duke.edu/prod/emc00/PublicSignIn.aspx?&SessionID=fh8ei0fd0fh5ej1fe2&Lang=*
The Duke-Industry Statistics Symposium (DISS) is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine and co-sponsored by Amgen, ASA-NC Chapter, Boehringer-Ingelheim, ICSA, IQVIA, Janssen, Journal of Biopharmaceutical Statistics, Lilly, PAREXEL, PPD, SAS, UCB and ViiV. The symposium was established seven years ago to discuss challenging issues and recent advances related to the clinical development of drugs, biologics and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.